2-Methyl-1,4-naphthoquinone β-甲萘醌
CAS 58-27-5 MFCD00001681
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Analytical Standards, EP Standards, EP Standards L - M, Pharmacopeia & Metrological Institutes Standards, 分析/色谱
- {SNA} Biochemicals and Reagents, Cell Stress, Nitric Oxide and Cell Stress, Oxidative Stress Proteins and Reagents, Prenols, Vitamin K, Vitamin K3, Vitamins,
产品应用
- 生化研究。该品与亚硫酸氢钠加成即得维生素K3。
相关文献及参考
- Cossarizza, A., et al., Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry. Nat. Protoc. 4 , 1790-7, (2009) 摘要
- Gohil, V., et al.: Nat. Biotechnol., 28, 249 (2010),
- Hu, W., et al.: Anal. Biochem., 398, 245 (2010),
- Merck 14 ,5831
- Merck:14,5831
- Merck:14,5831 Beilstein:7(2)656
- Sakamoto, S., et al.: Anal. Bioanal. Chem., 396, 2955 (2010),
- Short: II/27B
- [1]. http://en.wikipedia.org/wiki/Menadione
安全信息
GHS Symbol
- H315 Causes skin irritation 会刺激皮肤
- H335 May cause respiratory irritation 可能导致呼吸道刺激
- H302 Harmful if swallowed 吞食有害
- H319 Causes serious eye irritation 严重刺激眼睛
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P305+P351+P338
- P305+P351+P338+P337+P313
- P301+P312+P330
- P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
- S37/39 Wear suitable gloves and eye/face protection 穿戴适当的手套和眼睛/面保护;
- S36 Wear suitable protective clothing 穿戴适当的防护服;
- S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
- S24 Avoid contact with skin 避免皮肤接触;
- S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护;
- R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Administration onto the skin SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1860 mg/kg/27W-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Tumorigenic - tumors at site of application REFERENCE : BJCAAI British Journal of Cancer. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants. RG21 2XS, UK) V.1- 1947- Volume(issue)/page/year: 7,482,1953
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Administration onto the skin SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 8400 mg/kg/21W-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors REFERENCE : CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 19,413,1959
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 75 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 18,185,1971
TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 230 mg/kg TOXIC EFFECTS : Vascular - other changes REFERENCE : JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 75,111,1942
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 50 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD691-490
TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Bird - chicken DOSE/DURATION : 100 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04- Volume(issue)/page/year: 43,125,1940
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Microorganism - not otherwise specified DOSE/DURATION : 6 ppm REFERENCE : POASAD Proceedings of the Oklahoma Academy of Science. (Oklahoma Academy of Science, c/o Executive Secretary-Treasurer, Southwestern Oklahoma State Univ., Weatherford, OK 73096) V.1- 1910/1920- Volume(issue)/page/year: 34,114,1953
TYPE OF TEST : DNA damage TEST SYSTEM : Human Fibroblast DOSE/DURATION : 20 umol/L REFERENCE : TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- Volume(issue)/page/year: 28,37,1985
TYPE OF TEST : Morphological transformation TEST SYSTEM : Rodent - mouse Embryo DOSE/DURATION : 750 ug/L REFERENCE : CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 16,477,1995
TYPE OF TEST : DNA damage TEST SYSTEM : Rodent - hamster Cells - not otherwise specified DOSE/DURATION : 15 umol/L REFERENCE : BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 42,1961,1991
TYPE OF TEST : Mutation in microorganisms TEST SYSTEM : Bacteria - Salmonella typhimurium DOSE/DURATION : 30 nmol/plate REFERENCE : BBRCA9 Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 94,737,1980
TYPE OF TEST : Sister chromatid exchange TEST SYSTEM : Human Lymphocyte DOSE/DURATION : 10 nmol/L REFERENCE : CNREA8 Cancer Research. (Public Ledger Build
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE : 20 mg/kg SEX/DURATION : female 8 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system REFERENCE : TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954- Volume(issue)/page/year: 8,175,1961
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE : 3 gm/kg SEX/DURATION : female 1-20 day(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - musculoskeletal system REFERENCE : NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944- Volume(issue)/page/year: 69,285,1973
其他信息
- 用途二:生化研究,临床药物属脂溶性维生素,临床作为止血药。
- 所属类别二:食品添加剂: 营养强化剂(营养增补剂): 维生素
- 所属类别三:饲料添加剂: 维生素添加剂
- 上游原料:三氧化铬 --> 重铬酸钠 --> 重铬酸钾 --> 1,3-丁二烯 --> 1-甲基萘 --> 2-甲基萘 --> 甲基萘
- 用途一:饲料添加剂原料,主要能促进畜禽肝脏合成凝血酶原,并促进血浆凝血因子在肝脏内合成
- 参考质量标准二:GB7294—87 含量(以C11H9O5SNa·3H2O计)/% 60.0~75.0 亚硫酸氢钠含量
- 方法二:2-甲基萘经铬酐氧化,再与亚硫酸氢钠反应制得。
- MOL 文件:58-27-5.mol
- 溶于乙醇(1 G/60 ML) 、苯(1 G/10 ML)、氯仿、四氯化碳和植物油(1 G/50 ML)等,不溶于水。遇光或铁质分解变质,能随水蒸气挥发。
- 敏感性:Light Sensitive
- 用途四:该品与亚硫酸氢钠加成即得维生素K3。
- 用途五:生化研究。该品与亚硫酸氢钠加成即得维生素K3。
- 参考质量标准一:含量≥94%,磺酸甲萘醌合格。
- 用途三:维生素K3主要用作禽类饲料强化剂。用量1-5mg/kg。
- color:yellow
- 使用限量:GB 14880—94:婴幼儿食品,420~750,v.g/kg。
- 甲萘醌价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 SM562501 维生素K3 25g 515元 2011/04/16 M0373 2-甲基-1,4-萘醌 2-Methyl-1,4-naphthoquinone 250G 2310元 2011/04/16 M0373 2-甲基-1,4-萘醌 2-Methyl-1,4-naphthoquinone 25G 469元
- Alfa Aesar:2-甲基-1,4-萘醌,98% 2-Methyl-1,4-naphthoquinone, 98%(58-27-5)
- 所属类别一:生物化学品: 生化试剂: 辅酶和维生素
- 图谱信息:甲萘醌(58-27-5)红外图谱(IR2) 甲萘醌(58-27-5)核磁图( 13 CNMR) 甲萘醌(58-27-5)质谱(MS) 甲萘醌(58-27-5)核磁图( 1 HNMR) 甲萘醌(58-27-5)红外图谱(IR1)
- 方法一:以邻甲基萘醌为原料,经冰醋酸和铬酐氧化后在乙醇中与亚硫酸氢钠加成而得。
- F:8
- 方法三:有两种生产工艺。1.甲基萘用铬酐氧化而得。将2-甲基萘溶解于冰醋酸中,搅拌冷却到40℃以下,缓缓加入铬酐与等量水的混和液,使温度维持在35-40℃。加毕,在40℃保温0.5h,升温到70℃保温45min,再升温到85℃保温15min,将反应物倾入大量水中,不断搅拌下沉淀出2-甲萘醌。过滤,滤饼反复用水洗,至水溶液无酸味,滤干得2-甲萘醌。收率51%。2-甲基萘也可用重铬酸钠、重铬酸钾氧化收率大致相同。2.由甲苯醌与丁二烯环合得到2-甲基萘氢醌,再经铬酸氧化而得。将甲苯醌加入冰醋酸中溶解,通入丁二烯,在20℃以下通至所需量。密闭静置20h后,加热使剩余的丁二烯逸出,继续加热至110℃左右回流3h,再减压蒸馏回收冰醋酸约30%。然后冷却至40℃以下,缓缓加入铬酸与等量水的混合液,使温度保持在65-70℃,加毕,在70-80保温1h而生成甲萘醌。
- Acros Organics:2-甲基-1,4-萘醌酮/甲萘醌/维生素K3 2-Methyl-1,4-naphthoquinone, 98%(58-27-5)
- TCI Shanghai:2-甲基-1,4-萘醌 2-Methyl-1,4-naphthoquinone,>;98.0%(LC)(T)(58-27-5)
- Sigma Aldrich:58-27-5(sigmaaldrich)